Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tropisetron with Risperidone for Schizophrenia
NCT00435370Phase 3Completed
- Sponsor
- Baylor College of Medicine
- Start
- Nov 2006
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in schizophrenia comparing Tropisetron + Risperidone with Placebo + Risperidone (2 arms). Primary endpoint: Measurement and Treatment Research to Improve Cognition in Schizophrenia Cognition Domains at 12 weeks. Started Nov 2006; status: completed.
02
Drugs
tropisetron
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00435370.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00435370.